Jeevan Scientific Technology
Jeevan Scientific Technology (JSTL) share price was ₹81.76 at the 28 Oct 2026 close; market capitalisation ₹164 Cr; P/E (TTM) 42.58; sector Healthcare. The share price rose 37.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹18.28 Cr, against ₹8.80 Cr a year earlier and net profit was ₹0.87 Cr, against −₹3.22 Cr a year earlier (compared with Jun 2025). Promoters held 30.00% of Jeevan Scientific Technology in Sep 2026, down 0.25 percentage points from Jun 2026. Its Tapetide Score is 54/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM
Peer Comparison
Healthcare › Healthcare Technology › Healthcare Research, Analytics & Technology
| ₹408.00 | 74.32 | 16,470 Cr | 3.39 | 0.34% | 6.54% | 8.35% | 3,613 Cr | 221 Cr | |
| ₹597.00 | 35.83 | 14,386 Cr | 4.58 | 0.38% | 12.78% | 15.40% | 3,892 Cr | 401 Cr | |
| ₹264.65 | — | 7,478 Cr | 10.92 | 0.00% | -46.73% | -45.62% | 30 Cr | -353 Cr | |
| ₹512.80 | 28.73 | 2,292 Cr | 5.02 | 0.39% | 12.83% | 16.36% | 336 Cr | 80 Cr | |
| ₹119.22 | 8.96 | 530 Cr | 1.26 | 0.47% | 9.14% | 11.73% | 441 Cr | 49 Cr | |
| Jeevan Scientific Technology (this company) | — | 42.58 | 164 Cr | 2.28 | 1.45% | 0.12% | 2.74% | 72 Cr | 5 Cr |
| ₹10.67 | 12.26 | 158 Cr | 5.08 | 0.00% | 13.73% | 15.37% | 100 Cr | 13 Cr | |
| Median 7 companies | ₹336.33 | 32.28 | 2,292 Cr | 4.58 | 0.38% | 9.14% | 11.73% | 336 Cr | 49 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 30.2%
- Company has a low return on equity of -0.01% over last 3 years.
- Promoter holding has decreased over last 3 years: -8.23%
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year Operating margin 16.14% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.39 | 8.06 | 10.13 | 11.07 | 12.88 | 11.4 | 12.51 | 10.06 | 8.8 | 12.38 | 19.07 | 21.29 | 18.28 |
| Expenses | 8.36 | 7.46 | 9.12 | 10.09 | 9.65 | 8.9 | 10.44 | 10.44 | 10.58 | 10.31 | 13.84 | 17 | 15.33 |
| Operating Profit | 2.03 | 0.6 | 1.01 | 0.98 | 3.23 | 2.5 | 2.07 | -0.38 | -1.78 | 2.07 | 5.23 | 4.29 | 2.95 |
| OPM % | 19.54% | 7.44% | 9.97% | 8.85% | 25.08% | 21.93% | 16.55% | -3.78% | -20.23% | 16.72% | 27.43% | 20.15% | 16.14% |
| Other Income | 0.3 | 0.26 | -0.11 | 0.23 | 0.11 | 0.16 | 0.23 | 0.15 | 0.33 | 0.2 | 0.14 | 0.29 | 0.17 |
| Interest | 0.23 | 0.26 | 0.15 | 0.33 | 0.33 | 0.45 | 0.43 | 0.55 | 0.54 | 0.55 | 0.54 | 0.41 | 0.44 |
| Depreciation | 1.47 | 1.43 | 1.4 | 1.64 | 1.51 | 1.49 | 1.48 | 1.77 | 1.74 | 1.69 | 1.6 | 1.61 | 1.7 |
| PBT | 0.63 | -0.83 | -0.65 | -0.76 | 1.5 | 0.72 | 0.39 | -2.55 | -3.73 | 0.03 | 3.23 | 2.56 | 0.98 |
| Tax % | 19.05% | -25.3% | -24.62% | -3.95% | 31.33% | 65.28% | 89.74% | -50.59% | -13.67% | 66.67% | 25.7% | 28.52% | 11.22% |
| Net Profit | 0.51 | -0.61 | -0.49 | -0.73 | 1.03 | 0.25 | 0.05 | -1.26 | -3.22 | 0.01 | 2.4 | 1.84 | 0.87 |
| EPS (₹) | 0.34 | -0.39 | -0.31 | -0.47 | 0.7 | 0.16 | 0.07 | -0.82 | -1.96 | -0.06 | 0.9 | 0.81 | 0.27 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.39 | 18.21 | 20.39 | 26.13 | 23.94 | 46.9 | 67.79 | 36.18 | 39.65 | 46.84 | 61.54 | 71.02 |
| Expenses | 15.59 | 15.01 | 16.96 | 20.27 | 30.02 | 29.41 | 51.02 | 34.82 | 35.01 | 39.37 | 51.74 | 56.48 |
| Operating Profit | 1.8 | 3.2 | 3.43 | 5.86 | -6.08 | 17.49 | 16.77 | 1.36 | 4.64 | 7.47 | 9.8 | 14.54 |
| OPM % | 10.35% | 17.57% | 16.82% | 22.43% | -25.4% | 37.29% | 24.74% | 3.76% | 11.7% | 15.95% | 15.92% | 20.47% |
| Other Income | 0.37 | 0.58 | 0.92 | 1 | 2.5 | 2.39 | 5.91 | 1.07 | 0.67 | 0.65 | 0.97 | 0.8 |
| Interest | 1.28 | 1.54 | 1.87 | 2.36 | 3.04 | 2.26 | 0.96 | 1.04 | 0.98 | 1.82 | 2.04 | 1.94 |
| Depreciation | 0.68 | 1.23 | 2.12 | 3.13 | 3.92 | 3.97 | 3.69 | 5.07 | 5.93 | 6.25 | 6.64 | 6.6 |
| PBT | 0.21 | 1.01 | 0.36 | 1.37 | -10.54 | 13.65 | 18.03 | -3.68 | -1.6 | 0.05 | 2.09 | 6.8 |
| Tax % | 104.76% | 10.89% | 69.44% | 18.25% | -18.6% | 13.99% | 33.78% | -16.58% | -17.5% | -20% | 50.72% | — |
| Net Profit | -0.01 | 0.9 | 0.11 | 1.11 | -8.59 | 11.74 | 11.94 | -3.07 | -1.33 | 0.05 | 1.03 | 5.12 |
| EPS (₹) | -0.02 | 0.97 | 0.1 | 0.73 | -5.61 | 7.67 | 7.8 | -1.97 | -0.84 | 0.08 | 0.58 | 1.92 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 6.52% | 15.38% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.04 | 9.28 | 11.46 | 15.3 | 15.3 | 15.3 | 15.3 | 15.48 | 15.48 | 15.83 | 19.92 |
| Reserves | -2.27 | 7.6 | 10.55 | 16.53 | 7.92 | 19.72 | 35.28 | 32.71 | 32.95 | 34.11 | 52.02 |
| Borrowings | 11.08 | 8.45 | 18.78 | 18.15 | 17.95 | 10.34 | 12.55 | 10.1 | 13.41 | 20.58 | 21.28 |
| Other Liabilities | 5.56 | 5.56 | 8.59 | 11.32 | 12.7 | 20.62 | 14.75 | 7.63 | 6.03 | 7.77 | 13.37 |
| Total Liabilities | 20.41 | 30.89 | 49.38 | 61.3 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 107 |
| Fixed Assets | 8.67 | 16.35 | 28.17 | 32.59 | 30.54 | 27.38 | 19.07 | 24.97 | 26.66 | 34.55 | 36.08 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.9 | 2.81 | 4.71 | 4.71 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.98 |
| Other Assets | 11.74 | 14.54 | 21.21 | 28.71 | 23.33 | 38.6 | 58.81 | 39.05 | 38.4 | 39.03 | 62.82 |
| Total Assets | 20.41 | 30.89 | 49.38 | 61.3 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 107 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3.55 | -5.62 | 5.65 | 4.04 | -0.01 | 4.95 | 19.56 | -6.41 | 2.89 | 10.07 | 0.42 |
| Investing | -3.63 | -8.9 | -14.35 | -7.87 | -1.9 | -0.8 | -1.2 | -6.93 | -11.53 | -15.62 | -9.98 |
| Financing | 0.23 | 14.57 | 9.86 | 6.08 | 0.44 | -0.13 | 5.67 | -9.54 | 2.35 | 5.24 | 18.83 |
| Net Cash Flow | 0.15 | 0.05 | 1.17 | 2.25 | -1.47 | 4.02 | 24.03 | -22.88 | -6.29 | -0.3 | 9.26 |
| Free Cash Flow | -0.08 | -14.52 | -8.7 | -3.83 | -1.91 | 4.15 | 17.33 | -14.57 | -9.14 | -5.96 | -7.76 |
| CFO/OP | 197 | -176 | 165 | 69 | 32 | 39 | 153 | -269 | 101 | 135 | 5 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 152 | 227 | 292 | 205 | 104 | 112 | 40.97 | 118 | 113 | 124 | 123 |
| Inventory Days | — | — | — | — | — | — | 72.11 | 106 | 104 | 156 | 227 |
| Days Payable | — | — | — | — | — | — | 98.78 | 323 | 205 | 305 | 458 |
| Cash Conversion Cycle | 152 | 227 | 292 | 205 | 104 | 112 | 14.3 | -99.23 | 11.85 | -25.63 | -109 |
| Working Capital Days | 52.05 | 90.6 | 35.44 | -3.07 | -101 | 37.36 | 10.18 | 111 | 137 | 128 | 121 |
| ROCE % | — | 12.69% | 6.75% | 8.22% | -16.39% | 36.77% | 27.58% | -4.34% | -1.03% | 2.8% | 5.01% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Jeevan Scientific Technology insights
61 extracted metrics + investor summaries across FY11–FY27.
Documents
Frequently Asked Questions about Jeevan Scientific Technology
What does Jeevan Scientific Technology Ltd do?
Where is Jeevan Scientific Technology Ltd (JSTL) listed?
Which sector does Jeevan Scientific Technology Ltd belong to?
What is the market capitalisation of Jeevan Scientific Technology Ltd?
What is the PE ratio of Jeevan Scientific Technology Ltd?
What is the 52-week high and low of Jeevan Scientific Technology Ltd?
Does Jeevan Scientific Technology Ltd pay dividends?
What is the Return on Equity (ROE) of Jeevan Scientific Technology Ltd?
Company Information
Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538837.md for Jeevan Scientific Technology Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.